With a market cap of $125.3 billion, Stryker Corporation (SYK) is a medical technology company that develops and markets innovative products and services for hospitals, healthcare providers, and patients across the United States and approximately 61 countries worldwide. The company operates through its MedSurg and Neurotechnology and Orthopaedics segments, offering a broad portfolio that includes surgical equipment, medical devices, robotic-assisted technologies, neurovascular solutions, and orthopedic implants.
The Portage, Michigan-based company is slated to announce its fiscal Q2 2026 results after the market closes on Thursday, Jul. 30. Ahead of the event, analysts expect SYK to report an adjusted EPS of $3.49, up 11.5% from $3.13 in the year-ago quarter. It has surpassed Wall Street's bottom-line estimates in three of the past four quarterly reports while missing on another occasion.
